Genistein enhances the radiosensitivity of breast cancer cells via G2/M cell cycle arrest and apoptosis

Molecules

Volumn 18, Issue 11, 2013, Pages 13200-13217

  Liu, Xiongxiong ^a,b,c   Sun, Chao ^a,b   Jin, Xiaodong ^a,b   Li, Ping ^a,b   Ye, Fei ^a,b,c   Zhao, Ting ^a,b   Gong, Li ^a,b   Li, Qiang ^a,b  

^a INSTITUTE OF MODERN PHYSICS   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Apoptosis; Breast cancer cells; G2 M arrest; Genistein; Radiosensitivity

Indexed keywords

ANTINEOPLASTIC AGENT; GENISTEIN;

APOPTOSIS; ARTICLE; DRUG EFFECT; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; RADIATION DOSE; RADIATION EXPOSURE; TUMOR CELL LINE;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; GENISTEIN; HUMANS; RADIATION TOLERANCE;

EID: 84888621181     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules181113200     Document Type: Article

References (41)

1. Ferlay, J.; Shin, H.R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127, 2893-2917.
2. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69-90.
3. Smith, B.D.; Smith, G.L.; Hurria, A.; Hortobagyi, G.N.; Buchholz, T.A. Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J. Clin. Oncol. 2009, 27, 2758-2765.
4. Biswas, D.K.; Averboukh, L.; Sheng, S.; Martin, K.; Ewaniuk, D.S.; Jawde, T.F.; Wang, F.; Pardee, A.B. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor. Mol. Med. 1998, 4, 454-467.
5. Parl, F.F.; Schmidt, B.P.; Dupont, W.D.; Wagner, R.K. Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading. Cancer 1984, 54, 2237-2242.
6. Crowe, J.P. Jr.; Gordon, N.H.; Hubay, C.A.; Shenk, R.R.; Zollinger, R.M.; Brumberg. D.J.; McGuire, W.L.; Shuck, J.M. Estrogen receptor determination and long term survival of patients with carcinoma of the breast. Surg. Gynecol. Obstet. 1991, 173, 273-278.
7. Anderson, W.F.; Chu, K.C.; Chatterjee, N.; Brawley, O.; Brinton, L.A. Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. J. Clin. Oncol. 2001, 19, 18-27.
8. Zha, L.; Qiao, T.; Yuan, S.; Lei, L. Enhancement of radiosensitivity by CpG-oligodeoxyribonucleotide-7909 in human non-small cell lung cancer A549 cells. Cancer Biother. Radiopharm. 2010, 25, 165-170.
9. King, R.W.; Jackson, P.K.; Kirschner, M.W. Mitosis in transition. Cell 1994, 79, 563-571.
10. Zhou, B.B.; Elledge, S.J. The DNA damage response: Putting checkpoints in perspective. Nature 2000, 408, 433-439.
11. Melchionna, R.; Chen, X.B.; Blasina, A.; McGowan, C.H. Threonine 68 is required for radiationinduced phosphorylation and activation of Cds1. Nat. Cell Biol. 2000, 2, 762-765.
12. Chang, C.C.; Hung, C.M.; Yang, Y.R.; Lee, M.J.; Hsu, Y.C. Sulforaphane induced cell cycle arrest in the G2/M phase via the blockade of cyclin B1/CDC2 in human ovarian cancer cells. J. Ovarian Res. 2013, 6,41.
13. Lindqvist, A.; Rodríguez-Bravo, V.; Medema, R.H. The decision to enter mitosis: Feedback and redundancy in the mitotic entry network. J. Cell Biol. 2009, 185, 193-202.
14. Ando, T.; Kawabe, T.; Ohara, H.; Ducommun, B.; Itoh, M.; Okamoto, T. Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage. J. Biol. Chem. 2001, 276, 42971-42977.
15. Schwartz, G.K.; Shah, M.A. Targeting the cell cycle: A new approach to cancer therapy. J. Clin. Oncol. 2005, 23, 9408-9421.
16. Alberts, D.S.; Garcia, D.J. An overview of clinical cancer chemoprevention studies with emphasis on positive phase III studies. J. Nutr. 1995, 125, S692-S697.
17. Tanos, V.; Brzezinski, A.; Drize, O.; Strauss, N.; Peretz, T. Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. Eur. J. Obstet. Gynecol. Reprod. Biol. 2002, 102, 188-194.
18. van Duursen, M.B.; Smeets, E.E.; Rijk, J.C.; Nijmeijer, S.M.; van den Berg, M. Phytoestrogens in menopausal supplements induce ER-dependent cell proliferation and overcome breast cancer treatment in an in vitro breast cancer model. Toxicol. Appl. Pharmacol. 2013, 269, 132-140.
19. Vandersickel, V.; Depuydt, J.; Van Bockstael, B.; Perletti, G.; Philippe, J.; Thierens, H.; Vral, A. Early increase of radiation-induced ?H2AX foci in a human Ku70/80 knockdown cell line characterized by an enhanced radiosensitivity. J. Radiat. Res. 2010, 51, 633-641.
20. Zhang, T.; Yu, H.; Dong, G.; Cai, L.; Bai, Y. Chamaejasmine arrests cell cycle, induces apoptosis and inhibits nuclear NF-?B translocation in the human breast cancer cell line MDA-MB-231. Molecules 2013, 18, 845-858.
21. Bergamaschi, D.; Samuels, Y.; Jin, B.; Duraisingham, S.; Crook, T.; Lu, X. ASPP1 and ASPP2: Common activators of p53 family members. Mol. Cell. Biol. 2004, 24, 1341-1350.
22. Sun, Y.; St Clair, D.K.; Xu, Y.A. NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells. Cancer Res. 2010, 70, 2880-2890.
23. Hermann, R.M.; Fest, J.; Christiansen, H.; Hille, A.; Rave-Fränk, M.; Nitsche, M.; Gründker, C.; Viereck, V.; Jarry, H.; Schmidberger, H. Radiosensitization dependent on p53 function in bronchial carcinoma cells by the isoflavone genistein and estradiol in vitro. Strahlenther. Onkol. 2007, 183, 195-202.
24. Sun, C.; Zhang, H.; Ma, X.F.; Zhou, X.; Gan, L.; Liu, Y.Y.; Wang, Z.H. Isoliquiritigenin enhances radiosensitivity of HepG2 cells via disturbance of redox status. Cell Biochem. Biophys. 2013, 65, 433-444.
25. Stoll, B.A. Eating to beat breast cancer: potential role for soy supplements. Ann. Oncol. 1997, 8, 223-225.
26. Li, Y.; Upadhyay, S.; Bhuiyan, M.; Sarkar, F.H. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene. 1999, 18, 3166-3172.
27. Wang, T.T.; Sathyamoorthy, N.; Phang, J.M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996, 17, 271-275.
28. Zava, D.T.; Duwe, G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer 1997, 27, 31-40.
29. Ferguson, D.O.; Sekiguchi, J.M.; Frank, K.M.; Gao. Y.; Sharpless, N.E.; Gu, Y.; Manis, J.; DePinho, R.A.; Alt, F.W. The interplay between nonhomologous end-joining and cell cycle checkpoint factors in development, genomic stability, and tumorigenesis. Cold Spring Harb. Symp. Quant. Biol. 2000, 65, 395-403.
30. Stucki, M.; Stagljar, I.; Jónsson, Z.O.; Hübscher, U. A coordinated interplay: proteins with multiple functions in DNA replication, DNA repair, cell cycle/checkpoint control, and transcription. Prog. Nucl. Acid Res. Mol. Biol. 2001, 65, 261-298.
31. Antonsson, B.; Martinou, J.C. The Bcl-2 protein family. Exp. Cell. Res. 2000, 256, 50-57.
32. Vogelstein, B.; Lane, D.; Levine, A.J. Surfing the p53 network. Nature 2000, 408, 307-310.
33. Halazonetis, T.D.; Gorgoulis, V.G.; Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 2008, 319, 1352-1355.
34. Mori, E.; Takahashi, A.; Yamakawa, N.; Kirita, T.; Ohnishi, T. High LET heavy ion radiation induces p53-independent apoptosis. J. Radiat. Res. 2009, 50, 37-42.
35. Stiewe, T. The p53 family in differentiation and tumorigenesis. Nat. Rev. Cancer 2007, 7, 165-168.
36. Moll, U.M.; Slade, N. p63 and p73: Roles in development and tumor formation. Mol. Cancer Res. 2004, 2, 371-386.
37. Nguyen, D.T.; Hernandez-Montes, E.; Vauzour, D.; Schönthal, A.H.; Rice-Evans, C.; Cadenas, E.; Spencer, J.P. The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway. Free Radic. Biol. Med. 2006, 41, 1225-1239.
38. Leung, H.Y.; Yung, L.H.; Poon, C.H.; Shi, G.; Lu, A.L.; Leung, L.K. Genistein protects against polycyclic aromatic hydrocarbon-induced oxidative DNA damage in non-cancerous breast cells MCF-10A. Brit. J. Nutr. 2009, 101, 257-262.
39. Sobottka, S.B.; Berger, M.R. Assessment of antineoplastic agents by MTT assay: Partial underestimation of antiproliferative properties. Cancer Chemother. Pharmacol. 1992, 30, 385-393.
40. Vindelov, L.L.; Christensen, I.J.; Nissen, N.I. Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry 1983, 3, 328-331.
41. Severson, R.K.; Nomura, A.M.; Grove, J.S.; Stemmermann, G.N. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 1989, 49, 1857-1860.